4885 — Muromachi Chemicals Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapContrarian

Annual income statement for Muromachi Chemicals, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.

	2019 May 31st	2020 May 31st	2021 May 31st	2022 May 31st	2023 May 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	5,420	5,280	4,943	5,681	6,291
Cost of Revenue
Gross Profit	1,466	1,585	1,652	1,733	1,752
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	5,445	5,279	4,711	5,245	5,922
Operating Profit	-25	1.3	232	436	369
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-56	10.6	200	426	351
Provision for Income Taxes
Net Income After Taxes	28.9	31.6	181	456	256
Net Income Before Extraordinary Items
Net Income	28.9	31.6	181	456	256
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	28.9	31.6	181	456	256
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	62.7	100	83.4	112	64.1
Dividends per Share